中文

← All funding rounds

Medra

United StatesAutonomous labsSan Francisco, United StatesPrivate

Website · medra.ai ↗

Builds general-purpose lab robots driven by AI that plan, run and analyse biology experiments on standard instruments, for drug discovery teams.

Disclosed total$52M
Rounds on record1
Latest round$52MSeries A · 2025-12-11
Last stated valuationNone stated
Investors named8
Research on record1highest level 1 · Exists

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date2026$52MEvidencelevel of each research entry12345
Closed roundResearch entry, at its level

Latest round, Series A, 2025-12-11: the record then held no research entry for the company. The first research entry is dated 2026-06-24; the highest level so far is 1 (Exists).

Rounds and research, on one timeline

  1. 2026-06-24
    Research

    Level 1 · Exists

    Medra launches an AI layer that plans and revises experiments for its robot lab, with a DARPA-funded project to turn written protocols into machine runs

    Medra's bet is that testing, not ideas, is now the slow step, so the reasoning should sit next to the robots. Its one worked example is its own: an antibody binding assay cut from three days to about 14 hours by dropping a two-day cloning step and tuning the rest, with no data shown. DARPA's money says the government wants protocols turned into robot runs; it is not a result.

    Timeline entry →medra.ai ↗

  2. 2025-12-11Series A
    Round

    $52M

    For: expand the platform, grow teams and deploy with biopharma partners

    Automated labHiringCommercial roll-out

    Company press release (Business Wire) as reposted; Lux, Neo and NFDG are named as existing investors, but no earlier round is disclosed.

    Lead · Human CapitalLux Capital ✓NeoNFDGCatalio Capital Management ✓Menlo Ventures ✓776Fusion Fund ✓

    On the deal: Armaan Ali (Co-founder, CEO & Managing Partner, Human Capital); Matt Kraning (Partner, Menlo Ventures)

    Announced by the company · roboticstomorrow.com ↗

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

On the investors' own sites

Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.

Its investors also backed

Other companies on this page whose rounds name the same investor.